Combating Pancreatic Cancer with Novel Drug Therapies
Unfortunately, standard chemotherapy for pancreatic cancer often yields disappointing results. Gemcitabine (Gemzar), the standard drug for this disease, shrinks tumors at a low rate. Yet, it does make some people with pancreatic cancer feel better, and improves survival rates for a few.
Researchers at the University of Chicago Center for Gastrointestinal Oncology are testing several promising new investigational therapies for pancreatic cancer. Our oncologists are pioneers in this area--often being among the first to offer certain experimental treatments for the disease.
Participate in a Clinical Trial
Several clinical trials for pancreatic cancer are under way at the University of Chicago Medicine. View a list of open pancreatic cancer studies or contact us at 1-855-702-8222 for more information.